文献速递复苏、休克与脓毒症创伤与烧伤

800例大量输血方案事件后:尽管院内多项出血控制进展,失血性休克死亡率仍高且未变

After 800 Mtp Events, Mortality Due to Hemorrhagic Shock Remains High and Unchanged Despite Several In-Hospital Hemorrhage Control Advancements.
PubMed 文献 · Shock · 2021-01-01
一句话结论在824例大量输血方案患者中,12年间总体死亡率未下降(38.3%-56.6%,P=0.26),仅院前止血带与调整后死亡率降低独立相关(OR 0.39)。

该研究回顾性分析2008至2019年一家大型区域一级创伤中心全部大量输血方案(MTP)患者共824例,主要男性(80.6%)、穿透伤(68.1%),中位年龄31岁(23-44),新损伤严重度评分中位25(16-34)。按实施年份考察的干预包括MTP 1:1比例(2009)、液态血浆(2010)、氨甲环酸(2012)、院前止血带(2013)、REBOA/TEG(2017)、卫星血站(2018)和全血输注(2019)。总体死亡率未变(38.3%-56.6%,P=0.26);止血带(P=0.02)和全血(P=0.03)与未调整死亡率降低相关,仅止血带在调整后仍显著(OR 0.39,95%CI 0.17-0.89,P=0.03)。作者认为,在该高MTP量机构,失血性休克死亡率未改善,提示实施新的院内策略不足以降低死亡率,未来努力应转向将出血控制和有效复苏干预移至受伤现场。

要点

  • 824例MTP患者12年间总体死亡率未变(38.3%-56.6%,P=0.26),提示院内多项出血控制进展未转化为生存获益。
  • 调整后仅院前止血带与死亡率降低独立相关(OR 0.39,95%CI 0.17-0.89,P=0.03),全血输注未调整时相关(P=0.03)但调整后不显著。
  • 队列以穿透伤为主(68.1%)、男性80.6%,中位年龄31岁(23-44),新损伤严重度评分中位25(16-34)。
  • 作者认为:实施新的院内策略不足以降低死亡率,未来应把出血控制和有效复苏干预移至受伤现场。

适用人群与场景

  • 2008至2019年在一家大型区域一级创伤中心接受大量输血方案(MTP)治疗的全部患者,共824例。
  • 队列以男性为主(80.6%),穿透伤机制占68.1%,中位年龄31岁(23-44),新损伤严重度评分中位25(16-34)。

研究设计与关键结果

  • 研究类型:回顾性综述,纳入2008至2019年一家大型区域一级创伤中心全部MTP患者824例。
  • 按实施年份考察的干预:MTP 1:1比例(2009)、液态血浆(2010)、氨甲环酸(2012)、院前止血带(2013)、REBOA/TEG(2017)、卫星血站(2018)、全血输注(2019)。
  • 总体死亡率未变(38.3%-56.6%,P=0.26)。
  • 止血带与未调整死亡率降低相关(P=0.02),全血输注与未调整死亡率降低相关(P=0.03)。
  • 调整后仅止血带仍显著(OR 0.39,95%CI 0.17-0.89,P=0.03)。

证据类型、等级与局限

  • 证据类型:回顾性综述,单中心(一家大型区域一级创伤中心),样本量824例。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在该高MTP量机构,实施新的院内策略不足以降低死亡率;未来努力应转向将出血控制和有效复苏干预移至受伤现场。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Numerous advancements in hemorrhage control and volume replacement that comprise damage control resuscitation (DCR) have been implemented in the last decade to reduce deaths from bleeding. We sought to determine the impact of DCR interventions on mortality over 12 years in a massive transfusion protocol (MTP) population. We hypothesized that mortality would be decreased in later years, which would have used more DCR interventions.

STUDY DESIGN: This was a retrospective review of all MTP patients treated at a large regional Level I trauma center from 2008 to 2019. Interventions by year of implementation examined included MTP 1:1 ratio (2009), liquid plasma (2010), tranexamic acid (2012), prehospital tourniquets (2013), REBOA/TEG (2017), satellite blood station (2018), and whole blood transfusion (2019). Relative risk and odds of mortality for DCR interventions were examined.

RESULTS: There were 824 MTP patients included. The cohort was primarily male (80.6%) injured by penetrating mechanism (68.1%) with median (interquartile range) age 31 years (23-44) and New Injury Severity Score 25 (16-34). Overall mortality was unchanged [(38.3%-56.6%); P = 0.26]. Tourniquets (P = 0.02) and whole blood (WB) (P = 0.03) were associated with lower unadjusted mortality; only tourniquets remained significant after adjustment (OR: 0.39; 95% CI: 0.17-0.89; P = 0.03).

CONCLUSIONS: Despite lower mortality with use of tourniquets and WB, mortality rates due to hemorrhage have not improved at our high MTP volume institution, suggesting implementation of new in-hospital strategies is insufficient to reduce mortality. Future efforts should be directed toward moving hemorrhage control and effective resuscitation interventions to the injury scene.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Duchesne J, Taghavi S, Ninokawa S, et al. After 800 Mtp Events, Mortality Due to Hemorrhagic Shock Remains High and Unchanged Despite Several In-Hospital Hemorrhage Control Advancements. Shock. 2021. PMID: 34048424. doi:10.1097/SHK.0000000000001817

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。